Weeks 9-10: The Turn A noticeable shift occurs for most users around weeks 9-10
Key Findings from the Clinical Trial The study, led by Christian Hendershot at USC's Institute for Addiction Science, showed that weekly injections of semaglutide compared to placebo: Reduced alcohol cravings significantly Decreased drinking quantity overall Lowered the frequency of heavy drinking days What makes these results particularly exciting is that the magnitude of semaglutide's effects appeared potentially greater than what is typically seen with existing FDA-approved medications for alcohol use disorder, even though the drug was only administered at the lowest clinical doses
Rocha RI, Junior WC, Modolin MLA, Takahashi GG, Caldini ETEG, Gemperli R
Os dados disponveis at ao momento provm sobretudo de estudos clnicos de fase 2 , realizados em regime duplo cego, com um nmero relativamente limitado de pacientes, comparado com aquilo que ser necessrio para aprovao final
Proper hand washing and using sterile techniques are essential to prevent contamination during the mixing process
doi:10.3390/biomedicines9070728 66